Literature DB >> 12610559

Recombinant antibody microarrays--a viable option?

Christer Wingren1, Johan Ingvarsson, Malin Lindstedt, Carl A K Borrebaeck.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12610559     DOI: 10.1038/nbt0303-223

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  6 in total

1.  Conference report--protein microarrays in cancer and autoimmunity: tiny spots light up highlights of the ABRF 2004--integrating technologies in proteomics and genomics; February 28-March 2, 2004; Portland, Oregon.

Authors:  Sara M Mariani
Journal:  MedGenMed       Date:  2004-04-09

Review 2.  Functional genomics and proteomics: application in neurosciences.

Authors:  K E Wilson; M M Ryan; J E Prime; D P Pashby; P R Orange; G O'Beirne; J G Whateley; S Bahn; C M Morris
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

Review 3.  New technologies in cancer. Protein microarrays for biomarker discovery.

Authors:  Sergio Matarraz; María González-González; María Jara; Alberto Orfao; Manuel Fuentes
Journal:  Clin Transl Oncol       Date:  2011-03       Impact factor: 3.405

4.  Applications of protein microarrays for biomarker discovery.

Authors:  Niroshan Ramachandran; Sanjeeva Srivastava; Joshua Labaer
Journal:  Proteomics Clin Appl       Date:  2008-09-10       Impact factor: 3.494

5.  Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays.

Authors:  Anders Carlsson; Dirk M Wuttge; Johan Ingvarsson; Anders A Bengtsson; Gunnar Sturfelt; Carl A K Borrebaeck; Christer Wingren
Journal:  Mol Cell Proteomics       Date:  2011-02-24       Impact factor: 5.911

6.  Proteomic analysis and discovery using affinity proteomics and mass spectrometry.

Authors:  Niclas Olsson; Christer Wingren; Mikael Mattsson; Peter James; David O'Connell; Fredrik Nilsson; Dolores J Cahill; Carl A K Borrebaeck
Journal:  Mol Cell Proteomics       Date:  2011-06-14       Impact factor: 5.911

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.